S Ghosal, C J Taylor. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Ceftazidime/administration & dosageCeftazidime/adverse effectsCeftazidime/therapeutic useCystic Fibrosis/complicationsCystic Fibrosis/drug therapyDesensitization, Immunologic/methodsDrug Hypersensitivity/drug therapyDrug Hypersensitivity/prevention & controlHumansInfusions, IntravenousPseudomonas Infections/complicationsPseudomonas Infections/drug therapySkin Diseases/chemically induced
Substances: See more » Ceftazidime
Year: 1997 PMID: 9145836 DOI: 10.1093/jac/39.4.556
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790